Search by Drug Name or NDC
NDC 00065-0543-01 TRIESENCE 40 mg/mL Details
TRIESENCE 40 mg/mL
TRIESENCE is a OPHTHALMIC INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is TRIAMCINOLONE ACETONIDE.
Product Information
| NDC | 00065-0543 |
|---|---|
| Product ID | 0065-0543_f2ec8d15-d037-473a-8753-ca211c19e043 |
| Associated GPIs | 86300080101820 |
| GCN Sequence Number | 063905 |
| GCN Sequence Number Description | triamcinolone acetonide/PF VIAL 40 MG/ML INTRAOCULR |
| HIC3 | Q6P |
| HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
| GCN | 99617 |
| HICL Sequence Number | 035556 |
| HICL Sequence Number Description | TRIAMCINOLONE ACETONIDE/PF |
| Brand/Generic | Brand |
| Proprietary Name | TRIESENCE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | triamcinolone acetonide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mg/mL |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Labeler Name | Alcon Laboratories, Inc. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022048 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00065-0543-01 (00065054301)
| NDC Package Code | 0065-0543-01 |
|---|---|
| Billing NDC | 00065054301 |
| Package | 1 BLISTER PACK in 1 CARTON (0065-0543-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2007-11-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |